By employing a patient's genetic information, healthcare providers are now empowered to lessen the pain and costs of traditional trial and error methods when treating diseases and prescribing medications.
The customization of healthcare is the future. BASE10's commitment to medical decision-making and practices based on individual data is principal to all our programs. The utility of precision medicine delivers unique advantages that may positively impact an organization's financial and quality of care goals with far-reaching benefits to its human capital or patients.
BASE10 leverages precision nutrition science to gain insight into the effect diet choices have on chronic conditions. We offer an unprecedented level of engagement with dietitians that guide participants through their DNA results and tailor-made action plan. Our program offers a solution that is specifically geared to reducing financial expenditures by helping to reduce BMI and A1c .
BASE10’s Precision Medication Program revolves around the science of how genetics impacts patient response to medications. The program delivers insights to prescribers to support accuracy in medication and dosage selection for each individual patient. Our digital Precision Medication platform was built from scratch to deliver precise, personalized action-oriented recommendations that effectively guide clinical decision-making to the most vulnerable. BASE10’s Precision Medication Program aims to:
The Genetic Information Nondiscrimination Act (GINA) makes it against the law for health insurers to request, require, or use genetic information to make decisions about eligibility for health insurance and health insurance premiums, contribution amounts, or coverage terms. The Act also prohibits employment discrimination on the basis of genetic information.
BASE10 uses third-party cloud platforms that meet Health Insurance Portability and Accountability Act (HIPAA) and HITRUST requirements for the storage and access of protected data. BASE10 follows strict guidelines for the protection of customer data and does not engage in the selling or marketing of genetic data.